Voriconazole 137234-62-9 Large in supply CAS NO.137234-62-9

Synonyms: Voriconazole 2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol;Voriconazole solution;(2R,3S)-2-(2,4-Difluorophenyl)-3;2-(2,4-difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1,2,4-triazol-1-yl)butan-2-ol;2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1,2,4-triazol-1-yl)butan-2-ol;Voriconazole, >=98.5%;(2R,3S)-2-(2,4-Difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-((1H)-1,2,4-triazol-1-yl)-butan-2-;Voriconazole≥ 99.9% (HPLC, Dried basis)
CAS: 137234-62-9
MF: C16H14F3N5O
MW: 349.31
EINECS: 200-261-5
Product Categories: Fine Chemical;antifungal;API;Antifungal (Systemic);Inhibitors;Intermediates & Fine Chemicals;Pharmaceuticals;Aromatics;Heterocycles;Pfizer compounds;Inhibitor;ZINACEF
Mol File: 137234-62-9.mol
Voriconazole Structure
Voriconazole Chemical Properties
Melting point  127-130°C
Fp  9℃
storage temp.  Store at +4°C
solubility  DMSO: >20mg/mL
CAS DataBase Reference 137234-62-9(CAS DataBase Reference)
Safety Information
Hazard Codes  Xn,T,F
Risk Statements  22-36/38-52/53-48/22-40-25-61-39/23/24/25-23/24/25-11
Safety Statements  26-36-45-36/37-22-53-16
RIDADR  UN1230 - class 3 - PG 2 - Methanol, solution
RTECS  UV9145000

Voriconazole Usage And Synthesis
Product description Voriconazole is a broad-spectrum triazole antifungal ,it is primarily used for the treatment of progressive, possibly life-threatening infections in immune deficiency patients. Indications include: immunosuppressed patients with severe fungal infections, acute invasive aspergillosis (the most common pathogen is Aspergillus fumigatus, followed by A. flavus, Aspergillus niger and Aspergillus soil), severe invasive infections caused by fluconazole-resistant Candida (including C. krusei) severe infection caused by Foot actinomycetes bacteria genus and Fusarium bacteria genus . Moderate to severe renal insufficiency is administered intravenously paying caution.
Pharmacological interactions Combination With the CYP3A4 substrates, terfenadine, sirolimus, astemizole, cisapride, pimozide or quinidine , can increase blood concentrations of this drug, leading to QT prolongation, and occasionally torsades de pointes ventricular tachycardia.
Combination With Rifampicin, rifabutin, efavirenz, ritonavir (each 400mg, once every 12 hours), carbamazepine and phenobarbital, can significantly lower blood concentrations of voriconazole.
Combination with ergot alkaloids (ergotamine, dihydroergotamine) plasma concentrations of ergot drugs can cause increased ergot poisoning.
The above information is edited by the chemicalbook of Tian Ye.
Uses broad-spectrum antifungal
Chemical Properties Cyrstalline Solid
Uses An antifungal (systemic). An ergosterol biosynthesis inhibitor.
Uses antibacterial
Uses An antifungal. An Ergosterol Biosynthesis inhibitor
Definition ChEBI: A triazole-based antifungal agent used for the treatment of esophageal candidiasis, invasive pulmonary aspergillosis, and serious fungal infections caused by Scedosporium apiospermum and Fusarium spp. It is an inhibitor of cytochr me P450 2C9 (CYP2C9) and CYP3A4.
Biological Activity Triazole antifungal agent. Displays potent activity against Candida , Cryptococcus and Aspergillus species.